Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
ADPT stock delivered strong Q4 results, narrowing net loss from $61 million to $41 million. Adaptive Biotechnologies is positioned to capture multiple revenue tailwinds in 2023 as it prepares to ...
I was wrong about Carvana, and after another 150% gain, I still believe its 70x forward P/E is deceptive. Here's the data that shows why Carvana is a tech platform. Forget gross profit per unit; one ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results